Skip to main content
. 2021 Feb;22(2):341–347. doi: 10.31557/APJCP.2021.22.2.341

Table 1.

Comparison of Clinicopathological Parameters with the HIF-1α and LOXL-2 Immunoexpressions Using Kruskal-Wallis Test

Clinico-Pathological Parameter No. of cases HIF-1α expression LOXL-2 expression
Mean rank p- value Mean rank p-value
Tumor stage (T) Total 90 0.008* 0.968
T1 21 62.6 45.5
T2 33 41.29 46.68
T3 8 38.62 43.31
T4a 28 39.61 44.73
Nodal stage (N) Total 90 0.821 0.988
N0 31 43.18 46.19
N1 42 45.13 43.99
N2a 4 57.62 47.12
N2b 10 50.45 48.2
N2c 3 42 48.33
Clinical Stage Total 90 0.095 0.979
I 12 57.25 46.42
II 13 32.15 48.04
III 28 48.68 45.23
IVa 37 43.97 44.51
Histological grade Total 90 0.072 0.263
I 38 50.17 47.39
II 38 38.18 40.76
III 14 52.68 53.21

*, indicates significant result